About

Hong-Jun Yeh, PhD, is MicroMED’s Chief Operating Officer. Dr Yeh focuses on business strategic planning, client/partner development, leading and managing programmes and teams in drug/device combination
product commercialisation and lifecycle management through the integration of biologics process development, drug delivery device R&D, overall manufacturing processes and business development.

Dr Yeh has over 30 years (post-PhD) of diversified experience across R&D, manufacturing, supplier/CMO/quality/risk management, programme management and business development in the consumer products and biopharma/medical device industries at places like EWI, Baxter, J&J, Amgen Inc. (over 16 years) and EirGenix.

Contributions

WEARABLES

NOVEL SOLUTIONS FOR ULTRA-LARGE-VOLUME WEARABLE AND PORTABLE SUBCUTANEOUS INJECTORS

Dr Hong-Jun Yeh, Jiunn-Ru Lai and Tsung-Chieh Cheng discuss the need for novel approaches to the challenge of delivering high volumes of biologics while also addressing patient centricity, and introduce MicroMED’s two innovative gas-powered approaches that leverage micro-electromechanical systems to drive the injection.

More contributions

WEARABLES

ADVANCING SUBCUTANEOUS DELIVERY OF BIOLOGICS: A NOVEL REUSABLE MEMS-ENABLED ACTUATOR

Hong-Jun Yeh, Jiunn-Ru Lai and Tsung-Chieh Cheng explore the challenges and opportunities related to the subcutaneous delivery of biotherapeutics. They also highlight a novel reusable MEMS-enabled pneumatic actuation system designed to overcome these challenges.